Red Blood Cell Homeostasis:

Pharmacological Interventions to Explore Biochemical, Morphological and

Mechanical Properties. by Cluitmans, Jc et al.
ORIGINAL RESEARCH
published: 29 March 2016
doi: 10.3389/fmolb.2016.00010
Frontiers in Molecular Biosciences | www.frontiersin.org 1 March 2016 | Volume 3 | Article 10
Edited by:
Graça Soveral,
University of Lisbon, Portugal
Reviewed by:
Lars Kaestner,
Saarland University, Germany
Anna Bogdanova,
University of Zurich, Switzerland
*Correspondence:
Giel J. G. C. M. Bosman
giel.bosman@radboudumc.nl
Specialty section:
This article was submitted to
Cellular Biochemistry,
a section of the journal
Frontiers in Molecular Biosciences
Received: 30 December 2015
Accepted: 07 March 2016
Published: 29 March 2016
Citation:
Cluitmans JCA, Gevi F, Siciliano A,
Matte A, Leal JKF, De Franceschi L,
Zolla L, Brock R,
Adjobo-Hermans MJW and
Bosman GJGCM (2016) Red Blood
Cell Homeostasis: Pharmacological
Interventions to Explore Biochemical,
Morphological and Mechanical
Properties. Front. Mol. Biosci. 3:10.
doi: 10.3389/fmolb.2016.00010
Red Blood Cell Homeostasis:
Pharmacological Interventions to
Explore Biochemical, Morphological
and Mechanical Properties
Judith C. A. Cluitmans 1, Federica Gevi 2, Angela Siciliano 3, Alessandro Matte 3,
Joames K. F. Leal 1, Lucia De Franceschi 3, Lello Zolla 2, Roland Brock 1,
Merel J. W. Adjobo-Hermans 1 and Giel J. G. C. M. Bosman 1*
1Department of Biochemistry, Radboud University Medical Center, Nijmegen, Netherlands, 2Department of Ecological and
Biological Sciences, University of Tuscia, Viterbo, Italy, 3 Section of Internal Medicine, Department of Medicine, University of
Verona, Verona, Italy
During their passage through the circulation, red blood cells (RBCs) encounter severe
physiological conditions consisting of mechanical stress, oxidative damage and fast
changes in ionic and osmotic conditions. In order to survive for 120 days, RBCs adapt
to their surroundings by subtle regulation of membrane organization and metabolism.
RBC homeostasis depends on interactions between the integral membrane protein band
3 with other membrane and cytoskeletal proteins, and with key enzymes of various
metabolic pathways. These interactions are regulated by the binding of deoxyhemoglobin
to band 3, and by a signaling network revolving around Lyn kinase and Src family
kinase-mediated phosphorylation of band 3. Here we show that manipulation of the
interaction between the lipid bilayer and the cytoskeleton, using various pharmacological
agents that interfere with protein-protein interactions and membrane lipid organization,
has various effects on: (1) morphology, as shown by high resolution microscopy
and quantitative image analysis; (2) organization of membrane proteins, as indicated
by immunofluorescence confocal microscopy and quantitative as well as qualitative
analysis of vesicle generation; (3) membrane lipid organization, as indicated by flow
cytometric analysis of phosphatidylserine exposure; (4) deformability, as assessed in
capillary-mimicking circumstances using a microfluidics system; (5) deformability as
determined using a spleen-mimicking device; (6) metabolic activity as indicated by
metabolomics. Our data show that there is a complex relationship between red cell
morphology, membrane organization and deformability. Also, our data show that red
blood cells have a relatively high resistance to disturbance of membrane organization in
vitro, which may reflect their capacity to withstand mechanical, oxidative and osmotic
stress in vivo.
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INTRODUCTION
Despite constant exposure to oxidative and mechanical stress and fast changes in ionic and
osmotic conditions, erythrocytes survive for approximately 120 days in the circulation. In healthy
individuals, physiological wear and tear leads to the appearance of immune recognition and
removal signals, resulting in phagocytosis. This physiological aging process is disturbed by
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mutations in hemoglobin, membrane proteins or metabolic
enzymes (Bosman, 2004; Da Costa et al., 2013; Koralkova
et al., 2014), and by various multifactorial, systemic pathological
conditions such as inflammation (Dinkla et al., 2012).
RBC homeostasis is regulated by interactions between
proteins in and associated with the plasma membrane. These
interactions revolve around band 3. As the main component
of the two complexes that link the cytoskeleton to the
lipid bilayer (the “ankyrin complex” and the “junctional
complex”), band 3 plays a central role in the control of cell
morphology and deformability. Also, as a binding partner of both
deoxyhemoglobin and key enzymes of the glycolysis, band 3 is the
link between the oxygen-dependent, metabolic tradeoff between
the use of glucose either in glycolysis for production of ATP or in
the pentose phosphate pathway for protection against oxidation
by production of NADPH (Dzik, 2011). A signaling network
revolving around Lyn and Syk kinase-mediated phosphorylation
of band 3 is involved in the regulation of many, if not all these
processes. Activation of Syk is the initial signal of this pathway
and leads to tyrosine phosphorylation of band 3. Consecutively,
Lyn is activated and translocates to the membrane where it
phosphorylates its target residues on band 3 (Campanella et al.,
2005; Ferru et al., 2011).
Mutations in the main RBC proteins are associated with
altered morphology, decreased stability, and/or increased
removal, many of which result in anemia (Mohandas and
Gallagher, 2008). It has been proposed that mutations in
membrane proteins that affect horizontal or lateral interactions,
such as the spectrin dimer-dimer structure and the spectrin-
actin-protein 4.1R junctional complex, lead to elliptocytosis
and membrane fragmentation. Mutations in proteins involved
in vertical interactions, such as the binding of the spectrin
cytoskeleton to the band 3-ankyrin complex, are thought
to induce vesiculation-associated membrane loss, and the
concomitant appearance of spherocytes (Tse and Lux, 1999;
Mohandas and Gallagher, 2008). However, there is no clear
association, not even for a protein as central in membrane
organization as band 3, between genotype, RBC morphology
and clinical phenotype. Also, there is only a limited number
of data on the effect of a disturbance of membrane protein
interactions on RBC metabolism. Thus, there is an unmet need
for a molecular framework that explains the effect of alterations
in one protein on the interaction with its partners and the
concomitant effects on RBC morphology and function. Such
a framework would be of great benefit for understanding the
causes of anemia, including the role of vesiculation and the
spleen (Willekens et al., 2003).
It was the aim of this study to improve our understanding
of the structure-function relationship of the RBC membrane
morphology by treating RBCs with agents that disturb the
organization of the RBC cytoskeleton-membrane complex
through their effect on band 3. DIDS is an inhibitor of band 3-
catalyzed anion exchange that, upon binding to its membrane
domain, reduces the linkage between the lipid bilayer and
the cytoskeleton, resulting in an echinocyte cell shape (Van
Dort et al., 2001). Treatment of RBCs with the thiol-alkylating
reagent N-ethylmaleimide (NEM) modifies thiol groups in the
N-terminal cytoplasmic domain of band 3, and thereby disturbs
the ankyrin-band 3 interaction (Haratake et al., 2009; Blanc et al.,
2010). NEM also affects the phosphorylation status of band 3, by
acting as a protein phosphatase inhibitor (Bordin, 2002). Finally,
phosphorylation of band 3 was manipulated by treating RBCs
with the phosphatase inhibitor orthovanadate and the Src family
kinase-inhibitor PP2, both affecting the association of band 3
with the cytoskeleton (Low et al., 1987; Brunati et al., 1996, 2000;
Pantaleo et al., 2009; Ferru et al., 2011).
We compared the morphological, structural and functional
effects of these treatments. Even for interventions that all affect
the band 3 complex, a diversity of structural and functional
changes was observed. Our data show that the main current
theories, in which changes in cell morphology are directly linked
to disturbances in horizontal linkage within the lipid bilayer, or
to vertical linkages between the lipid bilayer and the cytoskeleton,
do not have sufficient heuristic power to explain all the structural
and functional changes.
MATERIALS AND METHODS
Sample Collection and Ethical Issues
Fresh RBCs were isolated from five ml whole blood (EDTA)
from healthy volunteers. RBCs were washed using Ringer
solution (125mmol/L NaCl, 5mmol/L KCl, 1mmol/L MgSO4,
2.5mmol/L CaCl2, 5 mmol/L glucose, 32mmol/LHEPES/NaOH,
pH7.4) by repeated centrifugation (5min, 1550 × g). This study
was carried out in accordance with the CCMO guidelines of the
Medical Ethical Committee of the Radboud University Medical
Center and with written informed consent from all subjects. All
subjects gave written informed consent in accordance with the
Declaration of Helsinki.
Treatments of the RBCs
RBCs (2% hematocrit) were incubated for 30 min at 37◦C in
Ringer solution containing 100 µM 4,4′-diisothiocyanostilbene-
2,2′-disulfonic acid (DIDS, Sigma-Aldrich, St. Louis MO, USA)
or 50 µM N-ethylmaleimide (NEM, Sigma-Aldrich, St. Louis
MO, USA). Phosphorylation was manipulated by incubation
with 100µMorthovanadate (Sigma-Aldrich, St. LouisMO, USA)
or 20 µM PP2 (Sigma-Aldrich, St. Louis MO, USA). PP2 was
dissolved in DMSO and then diluted in Ringer to a solution with
a final concentration of 0.1% DMSO. After treatment, the RBCs
were washed twice in Ringer solution by centrifugation (3 min,
400× g) before analysis.
Cell Classification
Cells were resuspended in Ringer solution, poured into Lab-Tek
chambered coverglass (Thermo Fisher Scientific, Rochester NY,
USA) and random field pictures were taken for morphological
classification. Microscopy was performed on a TCS SP5 confocal
laser scanning microscope (Leica Microsystems, Mannheim,
Germany) equipped with an HCX Plan-Apochromat 63X/N.A.
1.2 water immersion lens. Image J version 1.45j (U. S. National
Institutes of Health, Bethesda MD, USA, http://imagej.nih.gov/
ij/) was used for image analyses.
Frontiers in Molecular Biosciences | www.frontiersin.org 2 March 2016 | Volume 3 | Article 10
Cluitmans et al. RBC Homeostasis, Morphology and Deformability
Immunofluorescence
After treatment, the RBCs were fixated and stained as described
before (Matte et al., 2010). 1% BSA was used instead of fish
skin gelatin for blocking purposes. Primary antibodies and
relative dilutions were: mouse anti-stomatin (GARP-50, kindly
provided by Rainer Prohaska, University of Vienna, Austria) at
1:200, mouse anti-band 3 N-terminal domain (B3-136, Sigma-
Aldrich, St. Louis MO, USA) at 1:100 and mouse anti-band 3
C-terminal domain (IVF12, Developmental Studies Hybridoma
Bank, Iowa City, IA, USA) at 1:100. The secondary antibody
was goat anti-mouse Alexa-488 (Invitrogen, Carlsbad CA, USA)
at 1:1000 dilution. Image analysis and single cell fluorescence
determination were carried out using ImageJ version 1.45J.
Phosphatidylserine (PS) Exposure
After treatment, two million RBCs were resuspended in 25 µL of
Ringer and incubated for 45 minutes at room temperature in the
dark with Fluos–labeled annexin V (1:25, Roche, Indianapolis,
IN) to label exposed PS. After washing, the RBCs were analyzed
with a flow cytometer (FACSCalibur, BD Biosciences, Franklin
Lakes NJ, USA) and Cellquest Pro software version 6.0 (BD
Biosciences, Franklin Lakes NJ, USA) was used. Data analysis was
performed with Cyan Summit software v4.3 (Beckman-Coulter,
Fullerton CA, USA). Results are expressed as percentages of
annexin V–positive RBCs.
Measurement of Acetylcholinesterase
(AChE) Activity
AChE activity was measured using Ellman’s method (Salzer et al.,
2002), using 2 × 106 cells or, for vesicle measurements, the
supernatant of 2× 107 cells.
Microfluidics
RBC deformation within the microcapillaries was simulated
with a microfluidic device as described before, using 10 × 7
µm channels (Cluitmans et al., 2014). Cells were diluted to a
hematocrit of 2% in Ringer solution with 1% BSA. Perfusion of
the cell suspension through the microfluidic channels was done
with computer-controlled syringe pumps (neMESYS, Cetoni,
Germany) for accurate adjustment of the flow rates. In all
experiments a constant volumetric flow rate of 25 µl/h was
used, which corresponds to a flow velocity of 0.63 cm/s in the
narrow channel. Images of up to 1250 frames per second of the
field-of-view were recorded for quantitative image processing.
Cell flow was observed through a 100X oil immersion objective
(Olympus UPLFLN 100X, N.A. 1.30) using an optical microscope
(IX71, Olympus B.V., The Netherlands) equipped with a high
speed CMOS camera (Phantom high speed camera, Vision
Research, UK). Snapshots of RBC shape were obtained using
a short exposure time of 10ms. A sequence of images of
20,000 in each run was recorded. The RBCs in these images
were analyzed using the length and width of a rectangular box
enclosing the deformed RBCmeasured by a macro developed for
automated image processing using ImageJ. With these values, the
deformation index (DI), defined as the ratio between the sides
(DI= length/width) was calculated.
Bead-Sorting Device
RBC deformability was assessed using a bead-sorting device
that mimics the mechanical deformation that RBCs experience
in the spleen (Deplaine et al., 2011). RBCs were treated as
described above, after which the RBCs (1 × 108) were labeled
with CFSE diacetate (Thermo Fisher Scientific). A 2% hematocrit
suspension (600 µl) consisting of 5% treated/labeled and 95%
untreated/unlabeled RBCs in Ringer with 1% BSA was passed
through the bead-sorting device at a flow rate of 60 ml/h. The
untreated/unlabeled RBCs acted as both facilitators of steady
perfusion of the cells of interest, and as an internal control
for deformability. The percentages of CFSE-positive cells in the
various samples were determined by flow cytometry (100,000
cells), and the percentages in the retained and downstream
fractions were normalized to the labeled cells in the upstream
samples.
Phospho-Immunoblotting
Membrane fractions from control and treated red cells were
prepared as previously reported (De Franceschi et al., 1998,
2011; Iolascon et al., 2009). Proteins were separated by 1D-
electrophoresis, transferred to membranes, and probed with
the following specific antibodies: anti-Lyn antibody (2732, Cell
Signaling, USA), anti-phospho-Lyn (P-Lyn; Cell Signaling, USA),
anti-Syk (Cell Signaling; USA) and anti-phospho-Syk (P-Syk; Cell
Signaling; USA); anti-SH-PTP1 (SantaCruz; USA); Phospho-
Tyr 564 SH-PTP1 (anti-P-SH-PTP1 564; Cell Signaling, USA).
Densitometric analysis of band intensities was carried out by
Quantity One analysis software (Bio-Rad, Hercules, CA, USA)
(De Franceschi et al., 1997, 2011; Perrotta et al., 2005; Lupo et al.,
2016).
Metabolomic Analysis
Metabolomes were charted as described before (D’Alessandro
et al., 2013). In short, packed RBCs were lysed, extracted
with chloroform/methanol, and treated with acetonitrile to
precipitate proteins. Metabolites in the lysate were separated
on an Ultimate 3000 Rapid Resolution HPLC system with a
Reprosil C18 column. MS analysis was performed, both at
downstream negative and positive ion mode, on an electrospray
hybrid quadropole time-of-flight mass spectrometer MicroTOF-
Q (Bruker-Daltonik, Germany) equipped with an ESI-ion source.
Data were acquired with a stored mass range of m/z 50–
1200. The SmartFormula3D TM software (Bruker Daltonics) was
used to calculate molecular formulae based on the isotopic and
fragmentation patterns.
RESULTS
Cell Morphology and Membrane
Organization
To better define the structure-activity relationship of band 3 and
RBC morphology, we subjected RBCs to a series of treatments
known to interfere with band 3 function. Remarkably, in spite
of this restriction in the choice of compounds, very different
effects were observed. Incubation with DIDS at concentrations
known to induce band 3 crosslinking as well as the loss of low
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and high affinity ankyrin-binding sites, induced the formation
of stable echinocytes, as described before (Van Dort et al., 2001;
Ferru et al., 2011; Mrówczyn´ska et al., 2012). In contrast, NEM,
that affects the conformation of the cytoplasmic domain did
not have a distinct effect on morphology (Figure 1A), which is
in agreement with previous observations (Blanc et al., 2010).
An overall increase in phosphorylation status induced by the
phosphatase inhibitor orthovanadate resulted in the appearance
of echinocytes as well as spherocytes (Ferru et al., 2011).
Inhibition of Src-family kinase activity by PP2 did not show an
effect on cell morphology (Figure 1A).
In order to assess the effect of these treatments on the
interactions of band 3 with its partners in the membrane-
cytoskeleton complex, we investigated concomitant changes
in protein and lipid organization using immunofluorescence
confocal microscopy. Remarkably, membrane organization was
changed at the molecular level also after treatments that did
not have a visible effect on cell morphology. Staining with an
antibody against the N-terminal domain of band 3 shows a
punctuated pattern in control cells, that, upon treatment with
NEM, becomes much more diffuse (Figure 1). Treatment with
DIDS, which had a profound impact on morphology, induced
a similar pattern, at least in some cells. In contrast, the actin
antibody stains the control cells, but not the NEM-treated or
some of the DIDS-treated RBCs (Figure 1B).
Lipid distribution can also be influenced by changes
in the membrane-cytoskeleton complex organization, with
phospatidylserine (PS) exposure on the outside of the cell
membrane being the most prominent change, and associated
with vesiculation and aging (Kuypers and de Jong, 2004).
However, only orthovanadate led to an increase in PS exposure,
indicating that the disruption of the organization of band 3
complexes had no dramatic effect on PS distribution asymmetry
(Figure 1C).
Phosphorylation
We previously showed that the Syk-Lyn pathway plays a key role
in the modulation of membrane-cytoskeleton protein-protein
and protein-lipid bilayer interactions (Pantaleo et al., 2010; De
Franceschi et al., 2011; Lupo et al., 2016). Using cell fractionation
and immunoblot analysis, we evaluated the effect of various
treatments on membrane translocation of phospho-Syk (P-Syk)
and phospho-Lyn (P-Lyn), the active forms of these kinases (De
Franceschi et al., 2011). DIDS, NEM and orthovanadate led to
Syk and Lyn activation (Figure 2). In PP2-treated cells we found
a significant reduction in the membrane association of P-Lyn
compared to control cells, whereas no differences in membrane
association of P-Syk were observed (Figure 2). This finding is
in agreement with previous reports (Pantaleo et al., 2009; De
Franceschi et al., 2011). We then evaluated the phosphorylation
status of SH-protein tyrosine phosphatase-1 (SH-PTP1), as this
enzyme has been functionally linked to Lyn in various cell models
(De Franceschi et al., 2008; Nagao et al., 2014). Interestingly, we
observed a reduction in SH-PTP1 activation (P-SH-PTP1 Tyr
564) in RBCs treated with the Lyn inhibitor PP2 (Figure 2),
suggesting that Lyn may be a downstream regulator of SH-PTP1
in human RBCs.
Deformability
Deformability plays a key role in RBC functioning in vivo and
is closely related to the cytoskeleton-membrane interactions.
FIGURE 1 | Morphological and structural changes after treatment of RBCs. RBCs were treated with various reagents and analyzed as described in Materials
and Methods. (A) representative RBC morphologies after treatment of fresh RBCs from a healthy volunteer; (B) immunofluorescent staining of band 3 and actin; (C)
PS-positive RBCs expressed relative to the control (N = 3, *P < 0.05).
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FIGURE 2 | Phospho-immunoblot analysis of RBC membranes after treatment. Active Lyn (phospho(P)-Lyn 396), total Lyn, active Syk (phospho (P)-Syk), total
Syk, and active SH-PTP1 (phospho(P)-Tyr 564 SH-PTP1) were evaluated using specific antibodies (see also Materials and Methods). The representative experiment
shown is one of five similar experiments. Actin was used as loading control. The right panels show the data of a densitometric analysis of the immunoblots; data are
shown as means ±SD (n = 5; *P < 0.05; **P < 0.02 compared to control RBCs).
To further complement the morphological studies with a
dynamic assessment of deformability, we studied changes
in deformation capacity with two techniques that simulate
circulation through microcapillaries and passage through the
spleen in vivo.
Treatment with DIDS and NEM led to a decrease in
deformability in the microchannels of a microfluidic device
mimicking the microcapillaries (Cluitmans et al., 2014), as
did treatment with the Lyn kinase inhibitor PP2 (Figure 3A).
In contrast, an increase in the phosphorylation state upon
treatment with orthovanadate resulted in an increase in
deformability (Figure 3A). When RBCs were passed through
a bead-sorting device, mimicking the inter-endothelial slits in
the spleen, the capacity to deform was significantly impaired
after treatment with DIDS, whereas the other treatments had
no effect (Figure 3B). On the other hand, incubation with
DIDS was the only treatment that did not impair the capacity
of RBCs to elongate under large shear stress in the LORCA
ektacytometer or in the ARCA rheoscope (data not shown).
These findings are similar to those previously reported for DIDS
and NEM (Chasis and Mohandas, 1986; Van Dort et al., 2001;
Blanc et al., 2010). Vesiculation may be an important factor
that influences deformability by its effects on the surface-to-
volume ratio. The latter also affects osmotic fragility. Therefore,
in order to assess if changes in deformability where related
to changes in surface-to-volume ratio, we determined the
osmotic fragility of the treated cells. Almost all treatments
led to a decrease in osmotic fragility, with the exception of
treatment with orthovanadate, which had the opposite effect
(Figure 3C).
Vesicle Formation
It has been postulated that changes in membrane structure that
disrupt the binding of the cytoskeleton to the lipid bilayer induce
vesicle formation (Sens and Gov, 2006; Mohandas and Gallagher,
2008; Da Costa et al., 2013). Therefore, we measured vesicle
number and composition after treatment with DIDS and NEM.
All treatments—including the control incubation - induced
vesiculation, but the number of vesicles and the composition
differed between the control and the treatments. DIDS and NEM
treatment both led to a decrease in vesicle production (Figure 4),
but the vesicles that were formed did contain more of the
integral membrane protein band 3, the lipid-anchored protein
CD59, and displayed more of phosphatidylserine (PS) than the
control vesicles (Figure 4). These observations support previous
conclusions from proteomic analyses that vesicles may originate
by different mechanisms, depending on which molecular linkage
in themembrane-protein network is broken (Sens andGov, 2006;
Bosman et al., 2010, 2012). To investigate whether treatments
led to a breakage of protein contacts with subsequent release
of specific proteins in vesicles, we used the GPI-anchored
acetylcholinesterase as an independent, quantitative parameter
of vesicle production (Salzer et al., 2002). In line with our
results for band 3 and CD59, there was a treatment-associated
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FIGURE 3 | Deformability characteristics after treatment of RBCs.
RBCs were treated as described in Materials and Methods. (A) deformability
and relaxation as measured with a microfluidic device; (B) deformability and
retention as assessed with a spleen- mimicking device; (C) an osmotic fragility
assay to determine changes in the surface/volume ratio. The values in (A) are
the mean ± SE of at least 200 cells, *P < 0.05; the values in (B) are the mean
± SD of four measurements; the values in (C) are the mean of three
measurements with a standard deviation of less than 0.02 absorbance units.
effect. RBC acetylcholinesterase activity was decreased 20%
for DIDS, 10% for NEM and 5% for orthovanadate, with a
concomitant increase in the acetylcholinesterase activity in the
vesicle fractions.
Metabolism
Next to having an impact on RBC morphology and dynamic
behavior, changes in band 3 conformation and phosphorylation
may affect glycolysis as well as the pentose phosphate pathway
(PPP; Campanella et al., 2005; Dzik, 2011; Ferru et al., 2011).
In a series of pilot experiments, we found that incubation
of RBCs with DIDS had an inhibitory effect on glycolysis
(Cluitmans et al., unpublished). In physiological circumstances,
i.e., at ample glucose supply, a decrease in the rate of the
glycolysis is accompanied by an increase in the activity of
the pentose phosphate pathway (Dzik, 2011). In line with this
mutual interdependence, the same preliminary data indicated
that incubation with DIDS resulted in an increase in NADPH,
the primary product of the pentose phosphate pathway. In order
to explore the underlying, physiological signaling mechanisms,
we examined the effect of manipulation of phosphorylation
signaling on the metabolomic profile, using the RBCs of
three individuals. In contrast to our findings for DIDS, our
data did not show significant effects of manipulation of
phosphorylation on the concentration of glycolysis metabolites
(Figure 5). Orthovanadate increased the concentration of cyclic
AMP, indicating an overall effect on intracellular signaling, but
had no effect on inositol-1-phosphate and phosphatidylinositol-
3,4,5,-trisphosphate levels (Cluitmans et al., data not shown).
Also, we found no consistent effects of orthovanadate or PP2
on the pentose phosphate pathway intermediates, nor on the
reduced gluthation (GSH)/oxidized gluthation (GSSG) ratios.
Incubation with PP2 did not result in any significant changes
in the concentrations of the glycolysis or pentose phoshate
pathway intermediates (Figure 5). However, our data show
considerable inter-individual variability in the susceptibility to
such manipulations. This susceptibility extends to the effects of
DMSO, as a solvent control for PP2 (Figure 5).
DISCUSSION
Various mechanisms have been postulated for the generation
of abnormally shaped RBCs. These theories revolve around a
weakening of the linkage between the cytoskeleton and the lipid
bilayer. After an initial screening of a number of compounds,
we analyzed the effects of the band 3-directed agents DIDS,
NEM, PP2 and orthovanadate on various morphological and
functional RBC characteristics, protein localization at the plasma
membrane and RBC-derived vesicles. Overall, our data warrant a
critical revision of the current paradigms and of the experimental
approaches and pharmacological interventions commonly used
to investigate them.
Cell Morphology and Membrane
Organization
A comparison of the cell morphology and confocal
immunofluorescence data shows that changes in organization
of the membrane-cytoskeleton network are not always
accompanied by changes in cell morphology, and vice versa
(Figure 1). Immunoblot analyses of band 3 and spectrin did
not reveal any clear concomitant differences in membrane
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FIGURE 4 | Vesicle numbers and composition after DIDS and NEM treatment of RBCs. Cells were treated and the resulting vesicles were quantitated and
analyzed by flow cytometry and immunofluorescence as described in Materials and Methods. The data presented are the results of a series of pilot experiments.
protein composition (data not shown), but did show differences
in membrane protein phosphorylation state (Figure 2). The
effects of DIDS and NEM on phosphorylation are remarkable,
as both treatments do not directly interfere with kinase activity.
The absence of a relation between structural changes at the
membrane protein level and RBCmorphology has been reported
before, most notably in the case of aging-associated changes in
band 3 conformation (Willekens et al., 2008).
Measurement of PS exposure indicated that only treatment
with orthovanadate resulted in a significant disturbance of PS
distribution (Figure 1C). This may be due to an increase in
phosphorylation status of integral membrane proteins, but we
cannot exclude the possibility that orthovanadate inhibits the
activity of calcium-extruding ATP-ases with a concomitant rise
in intracellular calcium concentration, resulting in increased PS
exposure (Smriti et al., 2007; Bogdanova et al., 2013). Also,
although in erythrocytes band 3 is the most likely target of
DIDS, it cannot be excluded that some effects of DIDS may be
due to interference with other anion transporters, such as the
voltage-dependent anion channel (Sridharan et al., 2012). Again,
a comparison of PS exposure with cell morphology (Figure 1A),
showing the same echinocytic effect of both DIDS and
orthovanadate, indicates the absence of a consistent correlation
between cell morphology and membrane organization.
It has been stated that changes in cell morphology are mainly
caused by surface area loss, due to loss of vertical linkage between
the lipid bilayer and the cytoskeleton and/or to loss of lateral
protein interactions (Da Costa et al., 2013). The results of our
vesicle analyses suggest that changes in cell morphology may
not always be due to loss of membrane per se. A combination
of quantitative and qualitative vesicle analyses strongly indicates
that proteins are lost from the cell membrane as a result of
breaking contacts in the membrane-cytoskeleton complex. Each
disturbance of membrane organization results in a specific vesicle
population, and an associated loss of specific proteins. A similar
conclusion, that was based on theoretical considerations, has
been substantiated by a comparison of the vesicles generated
during aging in vivo with those generated during aging in vitro
in blood bank storage conditions (Sens and Gov, 2006; Gov et al.,
2009; Bosman et al., 2010, 2012). In addition, comparison of the
vesicle data with the PS data show that changes in membrane
lipid organization may be associated with, but are not essential
for, vesicle generation.
Cell Morphology, Membrane Organization
and Deformability
There is a notable lack of correlation between morphology
and deformability in the capillary-mimicking circumstances
of the microfluidic device. For example, an echinocytic
morphology induced by DIDS is associated with a decrease in
deformability, whereas the deformability of the morphologically
indistinguishable echinocytes induced by orthovanadate is
increased (Figures 1A, 3). It should also be noted that, although
DIDS and orthovanadate did not induce a shape change in all the
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FIGURE 5 | The effect of manipulation of phosphorylation on red blood cell metabolism. (A) glycolysis intermediates, presented as the means of three donors
with standard deviations; (B) glycolysis intermediates of three individual donors. For details see Materials and Methods.
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cells, deformability was changed for the whole cell population.
Furthermore, after treatment, misshapen cells behaved the same
in the microfluidic device as cells with a normal morphology,
suggesting that the effect on deformability is the direct result
of changes in membrane organization and that shape is not a
predictor of dynamic RBC behavior. In the data we have obtained
so far, no consistent correlation can be found for changes in
morphology, deformability, or PS exposure (Cluitmans et al.,
2012), while the latter parameters are expected to correlate with
retention in the spleen. The same conclusion was drawn before
for the RBCs of patients with neuroacanthocytosis. Acanthocytes
did not show any differences in deformability compared to
control cells (Cluitmans et al., 2015).
Conclusions on the effect of a change in membrane
organization on deformability are likely to depend on the
degree and type of mechanical stress employed. All treatments,
except for DIDS, decreased deformability when measured under
high shear stress in an ektacytometer (Cluitmans et al., data
not shown), while in the spleen-mimicking device only DIDS
led to a decrease in deformability. These differences trigger
the question on the biological relevance of the commonly
used deformability measurement techniques. Since the bead-
sorting and the microfluidic device measure deformability
under physiological conditions-mimicking circumstances, these
techniques seem to be preferable. It remains to be established if
and how the method of analysis itself contributes to the observed
effects. For example, high mechanical or osmotic stress may
themselves induce vesiculation (Ferru et al., 2011), and thereby
reduce deformability in susceptible RBCs, that have a normal
deformability in less stressful conditions. This could explain the
strongly reduced capacity of the DIDS-treated cells to pass the
spleen-mimicking device (Figure 1), and normal behavior in an
ektacytometer. Echinocytes may be more susceptible to vesicle
formation in these circumstances, which would lead to loss of
membrane and cell surface and thereby of deformation capacity.
Cell Morphology, Membrane Organization
and Metabolomics
Our data show that it is possible to manipulate RBC metabolism
by interfering with membrane organization in vitro, as has
been observed for stomatocytosis and sickle cell disease in
vivo (Darghouth et al., 2011a,b). Different treatments had
different effects on the concentrations of intermediates of the
glycolysis, of the closely associated pentose phosphate pathway
and on the glutathione concentration, albeit with a strong inter-
individual variance. Based on the glycolysis-enhancing effect
of deoxygenation, which reduces the binding of band 3 to
the cytoskeletal components ankyrin and/or adducin (Dzik,
2011), we postulated that interference with this binding in
vitro would result in an increase in glycolysis products and a
concomitant decrease in the pentose phosphate pathway and
in the reduced glutathione concentration. Indeed, in some
individuals, the effect of DIDS confirmed the role of band
3 in regulation of the glycolysis, and the concomitant effect
on production of ATP and on the redox status through
the ratio reduced/oxidized glutathione. The diverse effects of
manipulation of the Tyr-phosphorylation status of band 3 on
the metabolome indicate an intricate regulation of the main
energy-producing and redox status-regulating complexes of the
red blood cell. For example, in some individuals the inhibition
of Src family kinase (SFK)-mediated phosphorylation of band 3
was associated with an apparent decrease in the rates of both
the glycolysis and the pentose phosphate pathway (Figure 5).
Together with the asymmetrical effects of inhibition of SFK-
mediated phosphorylation and inhibition of phosphatase activity
(Figure 4), our data reveal the existence of a phosphorylation-
mediated signaling network for regulation of the metabolism that
involves more than the binding of glycolytic enzymes to band 3.
It is possible that enzymes of the pentose phosphate pathway also
bind to band 3, and that glycolysis enzymes also bind to other
membrane or cytoskeleton proteins, such as spectrin (Puchulu-
Campanella et al., 2013). The latter associations may be regulated
by alternative signaling pathways.
Notably, our data suggest large differences in the susceptibility
to the treatments between individuals. This may be due to genetic
variability in the characteristics of key enzymes in the various
metabolomic pathways and/or membrane transporters, or to the
inter-individual variability in the natural history of the red blood
cells.
Together, our metabolomic findings may provide another
starting point for identifying the pathways that regulate RBC
metabolism (Dzik, 2011; van’t Erve et al., 2014). Also, our
findings stress the putative value of the RBC as a model for
studying regulation of energy metabolism, with emphasis on
the possibility to study glycolysis as an isolated ATP-producing
process in situ.
CONCLUSIONS
From our pharmacological intervention-based approach aimed
to link cell morphology with deformability, membrane protein
modification and membrane lipid organization data, our main
conclusions, based on the data summarized in Table 1, are:
1. Themain current theories on the linkage between (changes in)
red blood cell morphology and disturbances in horizontal or
vertical associations in the membrane/cytoskeleton complex,
require a re-evaluation, since they do not explain all the
structural and functional observations;
2. Healthy RBCs have a large capacity to withstand disturbance
of membrane organization before this has functional
consequences in vitro; this may very well be a consequence of
the capacity to function in fast-changing conditions in vivo,
including mechanical, chemical and osmotic stress;
3. In order to understand the molecular mechanisms underlying
RBC-mediated pathology, physiologically relevant techniques
such as spleen-mimicking and capillary-mimicking devices,
reveal functional changes even if the morphology is
unaffected. Especially our microfluidic model may reveal
the impact of physiological, mechano-sensitive factors on
signaling, vesiculation, and metabolism;
4. Detailed analysis of the composition and organization of
RBC-derived vesicles is likely to yield more specific and
sensitive information;
5. It is possible to manipulate RBC metabolism by manipulating
membrane organization. Metabolomic analysis may turn out
Frontiers in Molecular Biosciences | www.frontiersin.org 9 March 2016 | Volume 3 | Article 10
Cluitmans et al. RBC Homeostasis, Morphology and Deformability
TABLE 1 | A summary of the effects of various treatments on morphological and functional characteristics of red blood cells.
Treatment Shape Band 3 PS Syk/Lyn Deformability Vesicles Glycolysis
MF SMD
Control D Punctuated 0 0 0 0 0 0
DIDS E Diffuse 0 + − − − −
NEM D Diffuse 0 + − 0 − 0
OV Sf ND + + + 0 ND 0
PP2 D ND 0 − − 0 ND 0
Cells were treated with DIDS, N-ethylmaleimide (NEM), orthovanadate (OV) or PP2, followed by morphological and functional analysis as described in Materials and Methods.
E, echinocytes; D, discocytes; Sf, sferocytes; PS, phosphatidylserine exposure; MF, microfluidics; SMD, spleen-mimicking device; 0, no change compared with
control; +, increased; −, decreased; ND, not determined. For details see Results.
to be an efficient approach for the identification of the
signaling routes that regulate the interaction between the RBC
and its organism-wide environment, both in healthy and in
pathological circumstances.
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